You are here:
Select the mission or strategic goal number below to track GAVI's progress against its targets for the 2011-2015 strategy:
GAVI Alliance Board paper defining both the key performance indicators that will be used to monitor progress against the 2011-15 GAVI strategy and how they are calculated.
Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.
© GAVI Alliance 2013
modal window here